Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as phase 1 clinical trial to treat glioblastoma. It is also developing BDTX-4933, a brain-penetrant RAF MasterKey inhibitor targeting KRAS, NRAS, and BRAF alterations in solid tumors that is in phase 1 clinical trial. In addition, the company is developing BDTX-4876, a MasterKey inhibitor of oncogenic FGFR2/3 mutations with selectivity versus FGFR1/4, which is in preclinical stage. The company was formerly known as ASET Therapeutics, Inc. and changed its name to Black Diamond Therapeutics, Inc. in January 2018. Black Diamond Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. more
Time Frame | BDTX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -9.06% | -2.12% | 0.77% |
1-Month Return | -26.75% | -2.54% | 2.65% |
3-Month Return | -55.37% | -6.28% | 12.3% |
6-Month Return | -48.17% | -1.36% | 13.48% |
1-Year Return | 1.69% | 9.29% | 33.47% |
3-Year Return | -59.01% | 10.05% | 32.22% |
5-Year Return | -93.9% | 43.69% | 92.85% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | 47.00K | 600.00K | 2.22M | 3.24M | 437.00K | [{"date":"2019-12-31","value":1.45,"profit":true},{"date":"2020-12-31","value":18.53,"profit":true},{"date":"2021-12-31","value":68.47,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":13.5,"profit":true}] |
Gross Profit | (47.00K) | (600.00K) | (2.22M) | (3.24M) | (437.00K) | [{"date":"2019-12-31","value":-4700000,"profit":false},{"date":"2020-12-31","value":-60000000,"profit":false},{"date":"2021-12-31","value":-221700000,"profit":false},{"date":"2022-12-31","value":-323800000,"profit":false},{"date":"2023-12-31","value":-43700000,"profit":false}] |
Gross Margin | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | (Infinity%) | [{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}] |
Operating Expenses | 29.33M | 69.57M | 126.87M | 92.83M | 86.46M | [{"date":"2019-12-31","value":23.12,"profit":true},{"date":"2020-12-31","value":54.83,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":73.17,"profit":true},{"date":"2023-12-31","value":68.15,"profit":true}] |
Operating Income | (8.90M) | (69.57M) | (126.87M) | (92.83M) | (86.46M) | [{"date":"2019-12-31","value":-890400000,"profit":false},{"date":"2020-12-31","value":-6957000000,"profit":false},{"date":"2021-12-31","value":-12687200000,"profit":false},{"date":"2022-12-31","value":-9282800000,"profit":false},{"date":"2023-12-31","value":-8646000000,"profit":false}] |
Total Non-Operating Income/Expense | (25.89M) | 6.36M | 4.74M | 3.69M | 5.94M | [{"date":"2019-12-31","value":-407.38,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":74.58,"profit":true},{"date":"2022-12-31","value":58.06,"profit":true},{"date":"2023-12-31","value":93.49,"profit":true}] |
Pre-Tax Income | (35.26M) | (67.25M) | (125.60M) | (88.92M) | (82.44M) | [{"date":"2019-12-31","value":-3525800000,"profit":false},{"date":"2020-12-31","value":-6725400000,"profit":false},{"date":"2021-12-31","value":-12559600000,"profit":false},{"date":"2022-12-31","value":-8891900000,"profit":false},{"date":"2023-12-31","value":-8244200000,"profit":false}] |
Income Taxes | 5.88M | (1.77M) | (2.39M) | (4.40M) | - | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-30.16,"profit":false},{"date":"2021-12-31","value":-40.66,"profit":false},{"date":"2022-12-31","value":-74.75,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (41.14M) | (65.48M) | (123.20M) | (84.52M) | - | [{"date":"2019-12-31","value":-4114300000,"profit":false},{"date":"2020-12-31","value":-6547900000,"profit":false},{"date":"2021-12-31","value":-12320300000,"profit":false},{"date":"2022-12-31","value":-8452000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | (35.26M) | (67.25M) | (125.60M) | (91.17M) | (82.44M) | [{"date":"2019-12-31","value":-3525800000,"profit":false},{"date":"2020-12-31","value":-6725400000,"profit":false},{"date":"2021-12-31","value":-12559600000,"profit":false},{"date":"2022-12-31","value":-9116900000,"profit":false},{"date":"2023-12-31","value":-8244200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (41.14M) | (65.48M) | (123.20M) | (84.52M) | (82.44M) | [{"date":"2019-12-31","value":-4114300000,"profit":false},{"date":"2020-12-31","value":-6547900000,"profit":false},{"date":"2021-12-31","value":-12320300000,"profit":false},{"date":"2022-12-31","value":-8452000000,"profit":false},{"date":"2023-12-31","value":-8244200000,"profit":false}] |
EPS (Diluted) | (4.74) | (2.05) | (3.47) | (2.52) | (1.88) | [{"date":"2019-12-31","value":-474,"profit":false},{"date":"2020-12-31","value":-205,"profit":false},{"date":"2021-12-31","value":-347,"profit":false},{"date":"2022-12-31","value":-252,"profit":false},{"date":"2023-12-31","value":-188,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
BDTX | |
---|---|
Cash Ratio | 5.42 |
Current Ratio | 5.55 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BDTX | |
---|---|
ROA (LTM) | -32.78% |
ROE (LTM) | -63.09% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BDTX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.29 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.71 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BDTX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 1.40 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Black Diamond Therapeutics Inc (BDTX) share price today is $2.41
Yes, Indians can buy shares of Black Diamond Therapeutics Inc (BDTX) on Vested. To buy Black Diamond Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BDTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Black Diamond Therapeutics Inc (BDTX) via the Vested app. You can start investing in Black Diamond Therapeutics Inc (BDTX) with a minimum investment of $1.
You can invest in shares of Black Diamond Therapeutics Inc (BDTX) via Vested in three simple steps:
The 52-week high price of Black Diamond Therapeutics Inc (BDTX) is $7.66. The 52-week low price of Black Diamond Therapeutics Inc (BDTX) is $2.31.
The price-to-earnings (P/E) ratio of Black Diamond Therapeutics Inc (BDTX) is
The price-to-book (P/B) ratio of Black Diamond Therapeutics Inc (BDTX) is 1.40
The dividend yield of Black Diamond Therapeutics Inc (BDTX) is 0.00%
The market capitalization of Black Diamond Therapeutics Inc (BDTX) is $132.97M
The stock symbol (or ticker) of Black Diamond Therapeutics Inc is BDTX